Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

20 Nov 2015 16:35

RNS Number : 5204G
Oxford Biomedica PLC
20 November 2015
 

Price Monitoring Extension

Today's closing auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's closing auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PMEBLBDBUXDBGUG
Date   Source Headline
5th Dec 20114:35 pmRNSPrice Monitoring Extension
28th Nov 20117:00 amRNSBlock Listing Six Monthly Return
16th Nov 20117:00 amRNSInterim Management Statement
18th Oct 20117:00 amRNSUS IND Approval for Novel Ocular Product
4th Oct 20114:39 pmRNSTR1 Form
4th Oct 20114:32 pmRNSTR1 Form
31st Aug 20119:00 amRNSTR-1: Notification of Major Interest in Shares
31st Aug 20118:18 amRNSInterim Results- Replacement
31st Aug 20117:00 amRNSInterim Results
4th Aug 20114:35 pmRNSPrice Monitoring Extension
4th Aug 20117:00 amRNSInterim Data from ProSavin® Phase I/II Study
8th Jul 20119:12 amRNSHolding(s) in Company
28th Jun 20117:00 amRNSNotice of Results
7th Jun 20117:00 amRNSResearch Agreement with ImaginAb
26th May 20117:00 amRNSBlock Listing Six Monthly Return
24th May 20117:00 amRNSManagement and Board Changes
19th May 20114:40 pmRNSSecond Price Monitoring Extn
19th May 20114:35 pmRNSPrice Monitoring Extension
18th May 20117:00 amRNSInterim Management Statement
5th May 201112:54 pmRNSAnnual General Meeting and Board Changes
4th May 20117:00 amRNSPfizer License Extension
3rd May 20117:00 amRNSAnnouncement of Data in ProSavin Study
15th Apr 20111:04 pmRNSDirectors' Interest in Shares and Share Options
14th Apr 20114:40 pmRNSSecond Price Monitoring Extn
14th Apr 20114:35 pmRNSPrice Monitoring Extension
4th Apr 201110:28 amRNSAnnual Information Update
31st Mar 20117:12 amRNSAnnual Report and Accounts & AGM Notification
22nd Mar 20117:00 amRNSDirector/PDMR Shareholding
21st Mar 20117:01 amRNSDirectorate Change
21st Mar 20117:00 amRNSStarGen US IND Approval
2nd Mar 20117:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2010
31st Jan 20114:40 pmRNSSecond Price Monitoring Extn
31st Jan 20114:35 pmRNSPrice Monitoring Extension
31st Jan 201112:20 pmRNSTotal Voting Rights Update
31st Jan 201112:19 pmRNSNotification of Major Interest in Shares
31st Jan 20117:00 amRNSAcquisition of Manufacturing Facility
20th Jan 20117:00 amRNSNotice of Preliminary Results
12th Jan 20118:20 amRNSHolding in Company
10th Jan 20118:47 amRNSDirectors' Interest in Shares
7th Jan 201111:30 amRNSResult of General Meeting
7th Jan 20117:00 amRNSResult of Open Offer
22nd Dec 20107:00 amRNSProSavin Phase I/II Update
14th Dec 20107:22 amRNSPublication of Prospectus
13th Dec 20104:50 pmRNSRe Proposed Fundraising
13th Dec 20107:47 amRNSProposed Fundraising
26th Nov 20107:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th Nov 20107:00 amRNSUS IND APPROVAL FOR RETINOSTAT
29th Oct 20107:00 amRNSOxford Biomedica PLC Interim Management Statement
26th Oct 20104:35 pmRNSPrice Monitoring Extension
26th Oct 20104:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.